Remove 2019 Remove Clinical Trials Remove Data Remove Presentation
article thumbnail

CBD Science Update

Project CBD

Over 200 scientists from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpiblished data. CBD for hypertension. Related story Can CBD Help Your Condition? Preclinical promise.

CBD 218
article thumbnail

GW Pharmaceuticals Pre-Announces Preliminary Unaudited Fourth Quarter and Full-Year 2019 Net Product Sales

Cannabis Law Report

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. 14th at 11:00 a.m. PT (2:00 p.m.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CBD Science Update

Project CBD

Just over 500 participants from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpublished data. CBD for hypertension. Related story Can CBD Help Your Condition?

CBD 177
article thumbnail

Medicinal cannabis users in the UK could be unfairly criminalised as study finds failures in roadside drug testing

Cannabis Law Report

The double-blind, randomised, placebo-controlled clinical trial took place over two years between 2017 and 2019 at the Center for Medicinal Cannabis Research at the University of California. Campaigners are calling for the government to revise the current laws and bring them up to date with contemporary data.

article thumbnail

Cannabis Helps, Say Over Half of Parkinson’s Patients Who Use It

The Cannigma

“Medical cannabis was legally approved in Germany in 2017 when approval was given for therapy-resistant symptoms in severely affected patients independent of diagnosis and without clinical evidence-based data,” lead investigator Professor Carsten Buhmann of the University Medical Center Hamburg-Eppendorf explained in a statement.

article thumbnail

Study: Oral CBD Use Has Anxiolytic and Anti-Psychotic Activity

The Joint Blog

This is according to a study published in the Journal of Clinical Medicine Research and epublished by the U.S. For the study researchers with the Nordic Cannabis Research Institute in Denmark reviewed 25 clinical trials assessing the safety and efficacy of CBD in various populations. National Institute of Health.

article thumbnail

Explore the Latest Studies for Veteran PTSD Research

Veriheal

According to data on Healthy Place , treatment for PTSD is typically accommodated for the general public, of who the vast majority have not experienced military combat. A 2019 study by Stephanie Lake and colleagues conducted an analysis of health survey data from more than 24 thousand Canadians who had PTSD.

Treatment 104